The regulation of both metabolism and the cell cycle has been intensely studied for decades due to their central roles in the etiology and progression of human disease. In the 1920s, Otto Warburg observed that cancerous tissues metabolize glucose at a much higher rate than normal tissue due to an increased rate of glycolysis. Since that discovery, numerous genetic and environmental factors associated with cancer progression have been linked to changes in cell metabolism.¹ An understanding of how cancerous cells bypass normal growth control mechanisms may be achieved through investigation of the crosstalk between metabolism and cell cycle regulation. Research in model systems such as C. elegans provides a foundation for understanding these crosstalk mechanisms. C. elegans possesses unique characteristics useful for phenotypic and genetic analyses, including a semi-transparent body that allows for direct visualization of cells at all developmental stages, established forward and reverse genetics methods and a streamlined genome that displays low redundancy while maintaining high conservation within specific gene families.² Perhaps the most useful characteristic for cell cycle analyses is the highly reproducible cell lineage that is subject to change only in response to genetic alteration or environmental distress.

C. elegans develops through a highly reproducible somatic cell lineage,^2,3 which suggests a high degree of spatiotemporal coordination between cell division, apoptosis, cell fate specification and differentiation.^4-7 In contrast to the embryo that enjoys the protection of the eggshell and is generally considered self-sufficient, the developing larvae must find a source of food if it is to survive and develop into a fertile adult. At two stages, C. elegans larvae are able to sense environmental cues, such as temperature, crowding and nutrition, and adapt their developmental programs to better suit ambient conditions.⁸ Immediately after hatching, the larvae make a developmental decision to proceed with post-embryonic development based on the availability of food.^9-11 Indeed, the ability to arrest post-embryonic development immediately after hatching in response to food deprivation, a state termed L1 diapause, and to resume larval development in response to food availability is experimentally exploited to generate large populations of synchronously developing larvae.¹² Similarly, upon exposure to unfavorable growth conditions during early larval development, the animals can adopt an alternate developmental program called the dauer stage.^8,13 Both of these developmental states are characterized by arrested cell cycles; however, the key distinguishing feature is that during dauer arrest, the larvae enter an alternative developmental program suited to withstand stressful conditions, while L1 diapause is simply a temporary arrest of larval development.¹³ Studies to delineate the developmental mechanisms used to regulate the cell cycle are uncovering an elaborate system of checks and balances that, together, ensure cell cycle progression occurs under the appropriate conditions and at the appropriate time.^5,14 Since the components and mechanisms involved in the cell cycle and its regulation are generally conserved with higher organisms, including humans, these studies are invaluable for understanding the molecular basis of and developing treatments for a wide variety of diseases.

Completion of a cell cycle carries a high energetic cost, thus the ability of a cell to sense its energy status and influence cell cycle progression is important for survival. Two important energy-sensing pathways, AMP-activated protein kinase (AMPK) and insulin/IGF-1 signaling have been well characterized in C. elegans in the context of aging, dauer formation and, more recently, cell cycle progression (Fig. 1). Specifically, these pathways have been implicated in controlling two separate cell cycle processes: G₁/S progression in somatic cells and G₂/M progression in the germ line. In this review, we discuss how these signaling pathways sense energy availability and override the genetically scheduled cell cycle to arrest cell divisions until conditions are favorable for further growth and development. In addition, pathways involved in oxygen sensing have been shown to regulate cell cycles in C. elegans; this suspended animation is discussed elsewhere in this issue by Padilla and Ladage.

Intensive investigation of the insulin signal transduction cascade in C. elegans has yielded a detailed mechanistic understanding of a process that is highly conserved among higher organisms.^15-18 These studies have revealed a core-signaling pathway that is involved in several nutrition-dependent developmental decisions described below. Several recent reviews have focused specifically on the mechanism of insulin/IGF-1 signal transduction;^15,19-22 thus, only those genes directly relevant to the discussion on cell cycle control are presented here. While approximately 40 genes have been identified as encoding putative insulin ligands,^23-26 a single gene called daf-2 encodes the insulin receptor.²⁷ The signaling cascade is initiated upon ligand engagement by DAF-2, which activates the AGE-1 PI3-kinase.²⁸ AGE-1 converts phosphoinositide-3,4-P2(PIP2) to phosphoinositide-3,4,5-P3 (PIP3). The increase in PIP3 concentration results in the activation of two AKT/PKB kinase homologs, AKT-1 and AKT-2.^29,30 The AGE-1 activity is counteracted by DAF-18, the C. elegans homolog of the phosphatase PTEN, which dephosphorylates PIP3.³¹ AKT-1 and AKT-2 regulate the nucleocytoplasmic localization of the DAF-16/FOXO transcription factor.^30,32-35 Phosphorylated DAF-16 is retained within the cytoplasm, such that active insulin signaling prevents DAF-16-mediated transcriptional activation.^32,33 This canonical pathway functions in the context of multiple processes, including response to UV exposure,³⁶ heat³⁵ or oxidative stress,³⁵ dauer formation²⁷ and aging.^27,37 As described below, the insulin/IGF-1 signaling pathway also plays a central role in regulating the cell cycle at both the G₁/S³⁸ and G₂/M transitions^10,39,40 of somatic and germ cells, respectively.

Insulin/IGF-1 signaling plays a vital role in initiating post-embryonic development of the newly hatched larvae. Specifically, in response to starvation, components of the insulin/IGF-1 pathway mediate a G₁-phase arrest of somatic cells during L1 diapause.³⁸ Based on the examination of several cell lineages, wild-type animals arrest cell divisions during L1 diapause, while animals deficient in daf-16/FOXO activity fail to arrest the cell cycle.³⁸ Accordingly, animals lacking the opposing daf-2 activity display a heightened sensitivity to food deprivation.³⁸ These findings establish that insulin signaling is an important contributor to nutrient-dependent G₁ cell cycle arrest in C. elegans. Further, the failure of daf-16/FOXO mutant animals to arrest cell divisions correlates with a failure to accumulate CKI-1/p27^kip1, suggesting that insulin/IGF-1 signaling controls L1 diapause arrest through the promotion of cyclin-dependent kinase inhibitory activity.³⁸ These results are supported by data obtained in other experimental systems demonstrating that FOXO transcription factors can regulate cell cycle progression through control of p27^kip1.^41-43 Although inactivation of daf-16/FOXO results in failure to accumulate CKI-1/p27^kip1 in C. elegans, further studies are needed to establish the precise mechanism of daf-16-mediated cell cycle arrest.

In addition to a role in starvation-induced G₁ arrest of somatic cells, insulin/IGF-1 signaling also mediates an arrest at the G₂/M transition in germ cells.^10,39,44 Analyses of animals lacking the p27^kip1-related G₁/S inhibitor encoded by cki-1 revealed over proliferation of a wide variety of somatic cell types,¹¹ but obvious hyperproliferation was not observed within the germ line.⁴⁴ This observation suggests that regulation of germ cell divisions does not occur at the G₁/S transition as in the somatic tissues.¹⁰ While primordial germ cells do, in fact, arrest cell cycles during L1 diapause, the cells arrest with 4N DNA content and duplicated centrosomes, indicating that the arrest occurs after completion of S phase.¹⁰ Similar to somatic cells, the germline cell cycle arrest in L1 diapause is dependent on components of the insulin/IGF-1 signaling pathway. Loss-of-function (lf) mutation within daf-18/PTEN allows germ cells to inappropriately proliferate during L1 diapause.¹⁰ The failure of germ cells to arrest in daf-18/PTEN(lf) mutant animals is due to overactive insulin/IGF-1 signaling, since further loss of the genetically opposing insulin/IGF-1 signaling components, such as age-1 or akt-1, suppress the hyperproliferation defect.¹⁰ Interestingly, daf-16 function is not required for germ cell arrest during L1 diapause.¹⁰ Since the proposed cell cycle quiescence function of DAF-16/FOXO is to promote expression of the G₁/S inhibitor CKI-1,³⁸ daf-16 function may be dispensable in organizing the G₂/M arrest of the germ cells. This suggests that the germline L1 diapause arrest may involve a non-canonical insulin/IGF-1 pathway that diverges prior to the activity of the canonical downstream effector, DAF-16/FOXO.

The requirement for insulin/IGF-1 signaling in germ cell arrest is not limited to L1 diapause, as insulin signaling components are also necessary for germ cell arrest during the dauer stage. At this stage, gain-of-function (gf) mutation of akt-1 or daf-18(lf) disrupts the ability of germline cells to arrest proliferation during the dauer stage.³⁹ In contrast to L1 diapause, daf‑16/FOXO activity appears to be required in the germ line for dauer stage proliferation arrest.³⁹ The differential requirement may reflect inherent differences between the mechanisms used to arrest germ cells during L1 and dauer stages. Despite these differences, it is clear that components of the insulin/IGF-1 signaling pathway play an indispensible role in sensing the low nutrient conditions and temporarily halting cell divisions within the germ line.

How does insulin/IGF-1 signaling exert control over the core cell cycle machinery to inhibit G₂/M progression in the germ cells? Interestingly, the cell cycle arrest requires the spindle assembly checkpoint (SAC), which delays the metaphase-to-anaphase transition until the sister chromatids have completed attachments to the mitotic spindle.⁴⁵ Animals that are hemizygous (i.e., Δ/+) for the SAC component encoded by mdf-1/MAD1 exhibit a germ cell hyperproliferation phenotype similar to daf-18(lf) mutant animals.⁴⁰ This hyperproliferation defect is not enhanced in combination with daf-18(lf), suggesting that daf-18 and mdf-1 may act within a linear pathway.⁴⁰ DAF-18 and MDF-1 appear to control the cell cycle through the activity of fzy-1, the C. elegans anaphase-promoting complex (APC) component, CDC20.⁴⁰ These genetic interactions support a model wherein the DAF-18/PTEN-mediated signaling pathway promotes germline cell cycle arrest through activation of the SAC, which, in turn, inhibits APC activity to result in cell cycle arrest.^40,46 A mechanism directly connecting insulin/IGF-1 signaling and the SAC is indicated by a bioinformatics analysis of AKT-1 that identified several potential phosphorylation sites on MDF-1, several of which could be phosphorylated by AKT-1 in vitro.⁴⁰ Moreover, expression of a phosphorylation site-defective MDF-1 weakly suppressed the daf-18(lf) hyperproliferation phenotype, suggesting that DAF-18 may mediate germ cell arrest during nutrient stress by preventing AKT-1 phosphorylation and inhibtion of MDF-1.⁴⁰ Together, these data suggest a mechanism to explain how the non-canonical insulin/IGF-1 signaling pathway can mediate a daf-16-independent G₂/M arrest through control of the SAC.

Insulin/IGF-1 signaling also plays an important role in the maintenance of germline proliferation under normal, non-starvation growth conditions. Animals carrying a temperature sensitive (ts) daf-2 allele that are grown at a semi-permissive temperature do not undergo dauer formation but display decreased germline proliferation, illustrating a constitutive role for insulin signaling in promoting germline proliferation.⁴⁷ The ability to separate germline arrest from dauer formation is notable, since it suggests that the cell cycle arrest does not depend on entry into the dauer arrest state.⁴⁷ The arrested germ cells of these daf-2(ts) mutant animals exhibited a 4N DNA content, consistent with a G₂/M delay.⁴⁷ The daf-2(ts) hypoproliferation defect also requires the activity of both daf-18/PTEN and daf-16/FOXO, indicating vital functions of the downstream targets of DAF-2 activation.⁴⁷ Based on RNAi analyses of putative insulin ligands, ins-3 and ins-33 may encode the insulin ligands that function to control germline proliferation.⁴⁷ A genetic screen for mutations that suppress germline tumor formation also found a vital role for daf-2 in germline proliferation. This model uses a gain-of-function allele of glp-1, one of two C. elegans Notch receptor homologs, to promote the production of a germline tumor.⁴⁸ The screen identified a daf-2(lf) mutation that suppresses germline tumor formation through daf-16/FOXO-dependent decrease of proliferation and increase in apoptosis.⁴⁹ Putative DAF-16/FOXO target genes that mediate the arrest were subsequently identified and included both positive and negative regulators of germline tumor formation.⁵⁰ Further analyses of these DAF-16 target genes may reveal the mechanism used by insulin/IGF-1 signaling to control germline proliferation.

The AMP-activated protein kinase (AMPK) signaling pathway is an ancient energy-sensing pathway that is conserved throughout eukaryotic evolution.⁵¹ A wide variety of metabolism-associated signals are integrated by AMPK through mechanisms that are poorly understood.⁵¹ Similarly, the mechanisms by which activated AMPK effects changes in the cell are not fully characterized,⁵¹ although its phosphorylation site specificity is well-documented.^52,53 Characterization of the AMPK heterotrimeric complex is complicated by the fact that higher organisms encode several isoforms of each subunit, which allows for the formation of multiple AMPK complexes.⁵¹ The C. elegans genome encodes two catalytic α subunits, aak-1 and aak-2; two β regulatory subunits, aakb-1 and aakb-2; and five γ regulatory subunits, aakg-1 through aakg-5.^54-56 Despite the potential of only 20 unique AMPK complexes in C. elegans, the assignment of a specific function to an individual complex has not yet been achieved. Through the study of other model systems, numerous targets of AMPK have been identified that implicate AMPK-mediated signaling in the positive regulation of catabolic processes and the negative regulation of anabolic processes through a variety of mechanisms.⁵¹ We will focus on the roles of AMPK signaling in the inhibition of cell cycle progression during low-nutrition development.

Using cultured mammalian cells, the critical role of AMPK signaling in nutrient-dependent G₁ arrest has been established. Cells expressing a constitutively active AMPK or treated with an activator of AMPK activity, AICAR, increase expression of p21^cip1, p27^kip1 and p53 and arrest divisions.^42,57,58 This arrest appears to be p53-dependent, since cells lacking p53 do not arrest following AMPK activation, and p53 phosphorylation coincides with activation of AMPK and glucose-dependent G₁ arrest.⁵⁸ Moreover, several tumor cell lines show low or no expression of the primary upstream kinase that activates AMPK, LKB1.⁵⁹ Consistent with its proposed role as a tumor suppressor, expression of LKB-1 in these cells results in elevated expression of the p21^cip1 cyclin-dependent kinase inhibitor and G₁ arrest.⁶⁰

In C. elegans, the crucial functions of AMPK in cell cycle control have only recently been revealed. Animals deficient for the AMPK catalytic subunit encoded by aak-2 failed to arrest somatic cell divisions during L1 diapause.³⁸ Although the molecular mechanism for the defect remains unknown, previously described results from mammalian studies suggest several possibilities. aak-2 may regulate cell cycle arrest by promoting the activity of the p53 homolog cep-1 or the cyclin-dependent kinase inhibitor orthologs cki-1 and cki-2. Since cep-1 has no known role in regulation of G₁/S progression in somatic cells,⁶¹ cki-1 and cki-2 are more likely candidates. Ultimately, unbiased identification of additional AMPK targets will clarify how AMPK controls cell cycle quiescence.

The AMPK requirement during induced cell cycle quiescence is better characterized in the germline than in somatic cells. Using a genetic screen to identify genes required to arrest germline proliferation in a temperature-sensitive dauer constitutive daf-2(ts) strain, a dominant-negative (Dn) allele of aak-2 was identified.³⁹ Here, despite the presence of food, the impaired daf-2(ts) activity results in dauer development and arrest of germ cell divisions.^27,39,62 The aak-2(Dn) allele disrupts the arrest and allows proliferation to proceed.³⁹ Using RNAi to inhibit the activity of the aak-1 ortholog, a weak germline hyperproliferation defect is also observed in the dauer stage.³⁹ However, the phenotype is significantly enhanced when aak-1(RNAi) is combined with the aak-2 mutation, suggesting that the two genes act in a redundant manner.³⁹ It is notable that a par-4/LKB1 mutation results in a phenotype similar to the aak-1;aak-2 double loss,³⁹ consistent with LKB1 as an activator of AMPK.⁵¹ Interestingly, the phenotype caused by this par-4 mutant allele is enhanced by additional loss of aak-2 function, suggesting that either (1) other upstream factors act redundantly on par-4 to regulate aak-2 or (2) the par-4 mutant allele used in this study still retains some ability to activate aak-2.³⁹ Furthermore, strd-1, the C. elegans homolog of the STRAD accessory protein that associates with LKB-1 to activate AMPK, is also required for germline arrest.⁶³ strd-1(lf) and par-4(lf) mutant animals display a similar hyperproliferation phenotype.⁶³ Consistent with in vivo cooperation between PAR-4 and STRD-1 to regulate AAK-2, phosphorylation of AAK-2 is not detected in either par-4(lf) or strd-1(lf) mutant animals.⁶³ Moreover, PAR-4 and STRD-1 appear to co-localize in early embryonic cells.⁶³ Taken together, these results delineate the AMPK-mediated mechanism that promotes germline cell cycle quiescence during dauer arrest.

Several studies in C. elegans suggest cooperation between insulin/IGF-1 and AMPK signaling. The extension of lifespan by reduced insulin/IGF-1 signaling requires aak-2 function,^54,55,64 indicating that AMPK acts downstream of insulin/IGF-1 signaling.^55,64 Subsequently, it was determined that lifespan extension by constitutive AMPK activation requires daf-16 function.⁶⁴ Since DAF-16 and FOXO3 are the targets of transcription activating phosphorylation by AMPK, a function for AMPK in lifespan extension may be to activate DAF-16.^64,65 Both aak-2(lf) and daf-16(lf) mutant animals exhibit the germ cell arrest failure phenotype in dauer,³⁹ consistent with AMPK activation of DAF-16 to promote germ cell arrest. However, genetic analyses of mutations disrupting other insulin/IGF-1 signaling components in combinations with the aak-2(lf) mutation suggest that AMPK and insulin/IGF-1 pathways may act within partially redundant mechanisms.³⁹ Further studies are clearly necessary to confirm the significance of DAF-16 co-regulation by AMPK and insulin/IGF-1 pathways to control cell cycle quiescence.

Studies of C. elegans demonstrate the presence of a nutrient-sensing system that is able to alter the highly ordered developmental cell lineage. We described two distinct stages when developing worms can modify their cell lineage programs upon encountering a low-food environment. First, the newly hatched larvae can delay post-embryonic development in a state referred to as L1 diapause until suitable nutrition is encountered. Second, in response to sub-optimal growth conditions encountered during the early larval stages, development can be directed toward an alternate L3 stage termed the dauer stage. While the transition into the dauer state also involves alterations to the cell fate program, both of these survival conditions necessitate changes to the normal timing of the energy intensive cell division cycles. Thus, while the genetically programmed cell lineage is highly reproducible under standard laboratory culture conditions, in less hospitable environments the developmental program exhibits a level of plasticity to facilitate survival of the animal.

C. elegans appear to mainly rely on the AMPK and insulin signaling pathways to induce cell cycle quiescence during conditions of low nutrient availability. While significant progress has been made, several outstanding questions remain regarding the functions of AMPK and insulin signaling pathways. Although clearly related to nutrient availability, the specific environmental cue or metabolite that initiates the insulin cascade to promote cell cycle quiescence is not defined. Nor is the mechanism used by AMPK to control cell cycles understood. Since several genes appear to act in a cell-autonomous manner, how the spatially and functionally unrelated cells coordinate initiation and maintenance of cell cycle arrest throughout the diverse cell types of the entire animal is not understood. Lastly, LKB1 was recently shown to play an AMPK-independent role in maintaining the quiescence of hematopoietic stem cells in mice.^66-68 Indeed, a function for AMPK signaling to control cell cycle progression during nutrient-replete C. elegans growth conditions has not been described. We suggest that the combined knowledge gained by studies of the intersection between metabolism and cell cycle using model systems such as C. elegans, Drosophila and mice can be developed into useful chemotherapeutic agents for treatment of a range of diseases from diabetes mellitus to cancer.